Hematopoiesis in MBL and CLL Versus Healthy Age-Matched Control Subjects

Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720

NCT01004965 ·Status: COMPLETED

S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia

NCT00899743 ·Status: COMPLETED

Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia

NCT01251159 ·Status: COMPLETED

S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia

NCT00899171 ·Status: COMPLETED

Study of Bone Marrow Samples From Patients With Acute Leukemia

NCT00897559 ·Status: COMPLETED

Biomarkers in Patients With Acute Myeloid Leukemia

NCT01138319 ·Status: COMPLETED

Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia

NCT00436904 ·Status: COMPLETED ·Phase: PHASE2

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

NCT00136422 ·Status: COMPLETED ·Phase: PHASE1

Cancer and Immune Cell Metabolism in Patients With Hematological Malignancies

NCT07189117 ·Status: RECRUITING

Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia

NCT01298414 ·Status: COMPLETED

Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia

NCT07146542 ·Status: NOT_YET_RECRUITING

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

NCT01120457 ·Status: COMPLETED ·Phase: PHASE1

Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia

NCT01642121 ·Status: COMPLETED

Study of the Immunological Infiltrate and Immunometabolic Immunometabolic Profile of Patients with Acute Leukaemia

NCT06814444 ·Status: RECRUITING

Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia

NCT01229956 ·Status: COMPLETED

Blinatumomab Maintenance After Allo-HSCT

NCT06438796 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

NCT03509896 ·Status: COMPLETED

Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia

NCT01421875 ·Status: COMPLETED

DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00899652 ·Status: COMPLETED

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

NCT00996047 ·Status: COMPLETED

Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL)

NCT07178912 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia

NCT01059734 ·Status: COMPLETED

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

NCT06180863 ·Status: WITHDRAWN ·Phase: PHASE2

Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing Through"Marrow-Blood Barrier"

NCT00155844 ·Status: UNKNOWN

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

NCT01466179 ·Status: COMPLETED ·Phase: PHASE2